184 related articles for article (PubMed ID: 38040221)
21. Prevention of cardiovascular disease in rheumatoid arthritis.
Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
[TBL] [Abstract][Full Text] [Related]
22. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; Liem AH; van de Geijn GM; van der Meulen N; Birnie E; van der Zwan EM; van Zeben J; Castro Cabezas M
Ann Rheum Dis; 2019 Mar; 78(3):335-341. PubMed ID: 30610067
[TBL] [Abstract][Full Text] [Related]
23. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
Westlake SL; Colebatch AN; Baird J; Kiely P; Quinn M; Choy E; Ostor AJ; Edwards CJ
Rheumatology (Oxford); 2010 Feb; 49(2):295-307. PubMed ID: 19946022
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
Drakopoulou M; Soulaidopoulos S; Oikonomou G; Tousoulis D; Toutouzas K
Curr Vasc Pharmacol; 2020; 18(5):488-506. PubMed ID: 32056527
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
[TBL] [Abstract][Full Text] [Related]
26. Microvascular endothelial dysfunction in rheumatoid arthritis.
Bordy R; Totoson P; Prati C; Marie C; Wendling D; Demougeot C
Nat Rev Rheumatol; 2018 Jul; 14(7):404-420. PubMed ID: 29855620
[TBL] [Abstract][Full Text] [Related]
27. Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities.
Arida A; Protogerou AD; Konstantonis G; Fragiadaki K; Kitas GD; Sfikakis PP
Rheumatology (Oxford); 2017 Jun; 56(6):934-939. PubMed ID: 28160488
[TBL] [Abstract][Full Text] [Related]
28. Increased cardiovascular risk in patients with rheumatoid arthritis: an overview.
Puttevils D; De Vusser P; Geusens P; Dens J
Acta Cardiol; 2014 Apr; 69(2):111-8. PubMed ID: 24783461
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk in rheumatoid arthritis.
Nurmohamed MT
Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
[TBL] [Abstract][Full Text] [Related]
30. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.
Semb AG; Ikdahl E; Wibetoe G; Crowson C; Rollefstad S
Nat Rev Rheumatol; 2020 Jul; 16(7):361-379. PubMed ID: 32494054
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
Fragoulis GE; Panayotidis I; Nikiphorou E
Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.
Turiel M; Tomasoni L; Sitia S; Cicala S; Gianturco L; Ricci C; Atzeni F; De Gennaro Colonna V; Longhi M; Sarzi-Puttini P
Cardiovasc Ther; 2010 Oct; 28(5):e53-64. PubMed ID: 20337633
[TBL] [Abstract][Full Text] [Related]
33. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.
Galarraga B; Belch JJ; Pullar T; Ogston S; Khan F
J Rheumatol; 2010 Mar; 37(3):521-8. PubMed ID: 20080919
[TBL] [Abstract][Full Text] [Related]
34. [Cardiovascular diseases in rheumatoid arthritis].
Nakajima A
Nihon Rinsho; 2016 Jun; 74(6):1012-6. PubMed ID: 27311194
[TBL] [Abstract][Full Text] [Related]
35. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
[TBL] [Abstract][Full Text] [Related]
36. [Kidney involvement in rheumatoid arthritis].
Icardi A; Araghi P; Ciabattoni M; Romano U; Lazzarini P; Bianchi G
Reumatismo; 2003; 55(2):76-85. PubMed ID: 12874640
[TBL] [Abstract][Full Text] [Related]
37. Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.
Scott DL; Ibrahim F; Farewell V; O'Keeffe AG; Ma M; Walker D; Heslin M; Patel A; Kingsley G
Health Technol Assess; 2014 Oct; 18(66):i-xxiv, 1-164. PubMed ID: 25351370
[TBL] [Abstract][Full Text] [Related]
38. How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?
Kerola AM; Kauppi MJ; Kerola T; Nieminen TV
Ann Rheum Dis; 2012 Oct; 71(10):1606-15. PubMed ID: 22736093
[TBL] [Abstract][Full Text] [Related]
39. [Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment].
Gerasimova EV; Popkova TV; Martynova AV; Markelova EI; Novikova DS; Kirillova IG
Ter Arkh; 2019 May; 91(5):34-39. PubMed ID: 32598674
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid use in rheumatoid arthritis patients and the onset of pneumonia: a systematic review and meta-analysis.
Elsouri KN; Arboleda V; Basbous L; Heiser S; Collins DP; Ragusa P; Baxter C; Cabrera D; Akhand T; Stermer E; Sharma K; Seguro C; Hardigan P; Kesselman M; Beckler MD
J Osteopath Med; 2023 Apr; 123(4):179-186. PubMed ID: 36691851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
